Pharmafrance Ltd. - Accounts to registrar (filleted) - small 18.2
Pharmafrance Ltd. - Accounts to registrar (filleted) - small 18.2
REGISTERED NUMBER: |
Pharmafrance Ltd. |
Unaudited Financial Statements |
for the Year Ended 31 March 2021 |
Pharmafrance Ltd. (by shares) (Registered number: 10599207) |
Contents of the Financial Statements |
for the year ended 31 March 2021 |
Page |
Company Information | 1 |
Chartered Accountants' Report | 2 |
Statement of Financial Position | 3 |
Pharmafrance Ltd. (by shares) |
Company Information |
for the year ended 31 March 2021 |
DIRECTOR: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: | Alton & Co |
Chartered Accountants |
239-241 Kennington Lane |
London |
SE11 5QU |
Chartered Accountants' Report to the Director |
on the Unaudited Financial Statements of |
Pharmafrance Ltd. (by shares) |
The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies. |
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pharmafrance Ltd. for the year ended 31 March 2021 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us. |
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance. |
This report is made solely to the director of Pharmafrance Ltd. in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pharmafrance Ltd. and state those matters that we have agreed to state to the director of Pharmafrance Ltd. in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmafrance Ltd. and its director for our work or for this report. |
It is your duty to ensure that Pharmafrance Ltd. has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Pharmafrance Ltd.. You consider that Pharmafrance Ltd. is exempt from the statutory audit requirement for the year. |
We have not been instructed to carry out an audit or a review of the financial statements of Pharmafrance Ltd.. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. |
Alton & Co |
Chartered Accountants |
239-241 Kennington Lane |
London |
SE11 5QU |
Pharmafrance Ltd. (by shares) (Registered number: 10599207) |
Statement of Financial Position |
31 March 2021 |
2021 | 2020 |
£ | £ |
CURRENT ASSETS |
CREDITORS |
Amounts falling due within one year | ( |
) | ( |
) |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
) |
( |
) |
CAPITAL AND RESERVES | ( |
) | ( |
) |
NOTE TO THE FINANCIAL STATEMENTS |
1. | AVERAGE NUMBER OF EMPLOYEES |
The average number of employees during the year was |
The director acknowledges her responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
Pharmafrance Ltd. (by shares) (Registered number: 10599207) |
Statement of Financial Position - continued |
31 March 2021 |
The financial statements were approved by the director and authorised for issue on |